Nasdaq
USD
Rydex Biotechnology C (RYCFX)
55.29
-1.07
(-1.90%)
At close: 8:03:49 PM EST
Fund Summary
Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.
Risk Overview
| Morningstar Risk Rating | |
| Best 1Y Total Return | 53.14% |
|---|---|
| Worst 1Y Total Return | -- |
| Number of Years Up | 17 |
| Number of Years Down | 7 |
Performance & Risk
| YTD Return | 30.93% |
| 5y Average Return | 7.78% |
| Rank in Category (ytd) | 12 |
| % Rank in Category (ytd) | -- |
| Beta (5Y Monthly) | 0.69 |
| Morningstar Risk Rating |
Risk Statistics
| 3 Years | 5 Years | 10 Years | ||||
|---|---|---|---|---|---|---|
| |
RYCFX | Category Average | RYCFX | Category Average | RYCFX | Category Average |
|
Alpha
|
5.65 | 0.04 | -1.5 | 0.03 | -0.94 | 0.07 |
|
BETA
|
0.69 | 0.01 | 0.71 | 0.01 | 0.83 | 0.01 |
|
Mean Annual Return
|
1.77 | 0.01 | 0.69 | 0.01 | 0.85 | 0.01 |
|
R-squared
|
22.09 | 0.6 | 37.23 | 0.52 | 40 | 0.5 |
|
Standard Deviation
|
17.61 | 0.21 | 17.32 | 0.19 | 19.4 | 0.17 |
|
Sharpe Ratio
|
0.95 | 0.01 | 0.25 | 0.01 | 0.39 | 0.01 |
|
Treynor Ratio
|
24.64 | 0.17 | 4.19 | 0.16 | 7.29 | 0.18 |
